ELEV

Elevation Oncology (ELEV)

About Elevation Oncology (ELEV)

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Details

Daily high

$0.53

Daily low

$0.51

Price at open

$0.52

52 Week High

$5.83

52 Week Low

$0.36

Market cap

30.3M

Dividend yield

0.00%

Volume

174,655

Avg. volume

735,836

P/E ratio

-.61

Elevation Oncology News